Larry Michael Mertz - 23 Jun 2022 Form 3 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Chief Technology Officer
Signature
/s/ Steve Reichling, attorney-in-fact
Issuer symbol
AXDX
Transactions as of
23 Jun 2022
Net transactions value
$0
Form type
3
Filing time
13 Jul 2022, 21:31:02 UTC
Next filing
22 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AXDX Common Stock 331,662 23 Jun 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AXDX Employee Restricted Stock Units 23 Jun 2022 Common Stock 25,671 Direct F1, F2, F3
holding AXDX Employee Restricted Stock Units 23 Jun 2022 Common Stock 71,642 Direct F2, F3, F4
holding AXDX Employee Stock Option (right to buy) 23 Jun 2022 Common Stock 100,000 $7.09 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person received an aggregate of 38,507 restricted stock units on May 20, 2021, of which 1/3 vested on May 20, 2022 and the remaining 2/3 will vest in two approximately equal installments on May 20, 2023 and May 20, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
F2 Not applicable.
F3 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F4 The reporting person received 71,642 restricted stock units on April 4, 2022, of which 40% vests on April 4, 2024 and the remaining 60% will vest on April 4, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
F5 The reporting person received a stock option to purchase 100,000 shares of the issuer's common stock on May 20, 2021, of which 1/3 vested on May 20, 2022 and the remaining 2/3 will vest in two approximately equal installments on May 20, 2023 and May 20, 2024.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney